Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Genetic therapy for spinal muscular atrophy

Nature Biotechnology volume 28, pages 235–237 (2010)Cite this article

Subjects

06 October 2022 Editor’s Note: readers are alerted that the primary research paper covered in this News & Views has been retracted.

A severe inherited neuromuscular disease is corrected in mice by intravenous gene delivery.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Gene therapy for mice with spinal muscular atrophy (SMA).

Change history

  • 06 October 2022

    Editor’s Note: readers are alerted that the primary research paper covered in this News & Views has been retracted.

References

  1. Foust, K.D. et al. Nat. Biotechnol. 28, 271–274 (2010).

    Article  CAS  Google Scholar 

  2. Crawford, T. in Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach (Jones R.H., De Vivo, D.C. & Darras B.T., eds.) 145–166 (Butterworth Heinemann, Philadelphia, 2003).

    Google Scholar 

  3. Narver, H.L. et al. Ann. Neurol. 64, 465–470 (2008).

    Article  Google Scholar 

  4. Burghes, A.H. & Beattie, C.E. Nat. Rev. Neurosci. 10, 597–609 (2009).

    Article  CAS  Google Scholar 

  5. Gavrilina, T.O. et al. Hum. Mol. Genet. 17, 1063–1075 (2008).

    Article  CAS  Google Scholar 

  6. Foust, K.D. et al. Nat. Biotechnol. 27, 59–65 (2009).

    Article  CAS  Google Scholar 

  7. McCarty, D.M. Mol. Ther. 16, 1648–1656 (2008).

    Article  CAS  Google Scholar 

  8. Smith, R.H., Levy, J.R. & Kotin, R.M. Mol. Ther. 17, 1888–1896 (2009).

    Article  CAS  Google Scholar 

  9. Clement, N., Knop, D.R. & Byrne, B.J. Hum. Gene Ther. 20, 796–806 (2009).

    Article  CAS  Google Scholar 

  10. Finn, J.D. et al. Mol. Ther. 18, 135–142 (2009).

    Article  Google Scholar 

  11. Kao, H.Y. et al. Clin. Chem. 52, 361–369 (2006).

    Article  CAS  Google Scholar 

  12. Pyatt, R.E., Mihal, D.C. & Prior, T.W. Clin. Chem. 53, 1879–1885 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Alex MacKenzie is at the Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.,

    Alex MacKenzie

Authors
  1. Alex MacKenzie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alex MacKenzie.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacKenzie, A. Genetic therapy for spinal muscular atrophy. Nat Biotechnol 28, 235–237 (2010). https://doi.org/10.1038/nbt0310-235

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0310-235

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research